SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (2162)3/4/2002 8:37:47 AM
From: Fred Levine  Read Replies (1) | Respond to of 2515
 
Concaito-- The probability standard that I mentioned of one of 20 by chance does not refer to the magnitude of the response. It refers to the reliability -- and hence the validity of the response. If it could be reliably determined that a drug works in 1% of the cases, it becomes a finding that refutes the hypothesis that the result is random. The 5% criterion is, I agree with you, not fixed in stone, but is the usual benchmark. The standard is a comparison between a random finding, which obviously can vary, and the obtained finding. The obtained must be demonstrated to be reliable, even if small, or we're back to anecdotal results.

fred



To: Cacaito who wrote (2162)3/4/2002 5:24:48 PM
From: Cacaito  Read Replies (1) | Respond to of 2515
 
Thomas Weisels and Partners: too much risk, uncertain stock, better options somewhere else.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News